icon-    folder.gif   Conference Reports for NATAP  
 
  AIDS 2022
July 29 - Aug 2
24th Intl AIDS Conference
Back grey_arrow_rt.gif
 
 
 
Long-Acting Cabotegravir + Rilpivirine in Older Adults: Pooled Phase 3 Week 96 Results
 
 
  AIDS 2022 July 29 - Aug 1 Montreal
 
Emilie R. Elliot1, Ronald D'Amico2, Andrew Clark1, Joseph W. Polli2, Louise Garside3, Jeremy Roberts4, Paul D. Benn1, Susan L. Ford5, Simon Vanveggel6,
Bryan Baugh7, Jean van Wyk1
1ViiV Healthcare, Brentford, United Kingdom; 2ViiV Healthcare, Research Triangle Park, NC, United States; 3PHASTAR, Macclesfield, United Kingdom; 4GlaxoSmithKline, Mississauga, ON, Canada; 5GlaxoSmithKline, Research Triangle Park, NC, United States; 6Janssen Research & Development, Beerse, Belgium; 7Janssen Research & Development, Titusville, NJ, United States

0729221copy

0729222copy

0729223copy

0729224copy

0729225copy

0729226copy

0729227copy

0729228copy

0729229copy

07292210copy